News
The company is preparing a Phase 3 trial of enobosarm with a novel formulation that could extend its patent life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback